SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001754526-23-000002
Filing Date
2023-10-23
Accepted
2023-10-23 16:23:52
Documents
1
Period of Report
2023-10-19

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 4  
1 PRIMARY DOCUMENT primary_doc.xml 4 6396
  Complete submission text file 0001754526-23-000002.txt   8181
Mailing Address 400 CROSSING BOULEVARD BRIDGEWATER NJ 08807
Business Address 400 CROSSING BOULEVARD BRIDGEWATER NJ 08807 9088091300
RVL Pharmaceuticals plc (Issuer) CIK: 0001739426 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L2 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address EDIFICIO AFRA AVENIDA SAMUEL LEWIS Y CALLE 54 PANAMA R1
Business Address EDIFICIO AFRA AVENIDA SAMUEL LEWIS Y CALLE 54 PANAMA R1 5072639355
Harsaul Foundation (Reporting) CIK: 0001754526 (see all company filings)

State of Incorp.: R1 | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-38709 | Film No.: 231340215